Pharm Exec1h
Preventing Silos During Product Launches: Q&A with Dan Rizzo
Dan Rizzo, global head of Veeva Business Consulting, spoke with Pharmaceutical Executive about the state of product launches ...
Pharm Exec1h
Finding Underserved Communities: Q&A with Biljana Naumovic of J&J
Biljana Naumovic discusses the importance of finding ways to reach out to underserved communites.
Pharm Exec1h
AI Drug Discovery Impact on Pharmaceutical Value Chain
In this Pharmaceutical Executive video interview, Edoardo Madussi, Head of Business Development, Intelligencia AI discusses ...
Pharm Exec16h
Merck Launches Phase III Trial Evaluating Zilovertamab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, and prednisone against the current standard-of-care in patients with ...